期刊文献+
共找到1,214篇文章
< 1 2 61 >
每页显示 20 50 100
Effect of minimally invasive intracranial hematoma drainage on inflammatory factors, serum ferritin and serum P substance in patients with hypertensive cerebral hemorrhage 被引量:2
1
作者 Sheng-De Nong Ming-Xiong Lu +3 位作者 Ting-Yang Li Hai-Chang Huang Jing Ye Chao-JueHuang 《Journal of Hainan Medical University》 2017年第1期113-116,共4页
Objective:To study the effect of minimally invasive intracranial hematoma drainage on inflammatory factors, serum ferritin and serum P substance in patients with hypertensive cerebral hemorrhage.Methods:92 cases of hy... Objective:To study the effect of minimally invasive intracranial hematoma drainage on inflammatory factors, serum ferritin and serum P substance in patients with hypertensive cerebral hemorrhage.Methods:92 cases of hypertensive cerebral hemorrhage patients in our hospital were selected and randomly divided into 2 groups: minimally invasive group (51 cases) and routine group (41 cases). Minimally invasive intracranial hematoma drainage was performed on the minimally invasive group. Bone flap decompression or small bone window craniotomy were used in the routine group. Tumor necrosis factorα (TNF-α), interleukin-6 (IL-6), high sensitive C reactive protein (hs-CRP) and serum protein (SF), serum substance P (SP) in the 2 groups were detected before treatment and 2 weeks after treatment.Results: The comparison of TNF-α, IL-6, hs-CRP, SP, and SF in the two groups before treatment was not statistically significant (P>0.05). TNF-α, IL-6, hs-CRP and SF in both groups after treatment significantly decreased, compared with that before treatment (P<0.01,P<0.05). TNF-α, IL-6, and SF in minimally invasive group decreased more significantly than that in routine group (P<0.01);The comparison of SP in the two groups after treatment significantly increased compared with that before treatment (P<0.01,P<0.05). SP in minimally invasive group increased more significantly than that in routine group (P<0.05).Conclusions:Compared with bone flap decompression or small bone window craniotomy, minimally invasive intracranial hematoma drainage can inhibit inflammatory reaction, reduce the degree of nerve damage and alleviate clinical symptoms more effectively. 展开更多
关键词 MINIMALLY invasive intracranial hematoma drainage HYPERTENSIVE cerebral hemorrhage Inflammatory factor SERUM FERRITIN SERUM P substance
下载PDF
TCD value for evaluating the intracranial hypertension and nerve injury in patients with hypertensive cerebral hemorrhage
2
作者 Li Guo Zhi-Yong Li Quan-Quan Yang 《Journal of Hainan Medical University》 2018年第1期137-140,共4页
Objective: To evaluate the assessment of intracranial hypertension and nerve injury in patients with hypertensive cerebral hemorrhage by transcranial Doppler (TCD). Methods: The patients who were hospitalized for hype... Objective: To evaluate the assessment of intracranial hypertension and nerve injury in patients with hypertensive cerebral hemorrhage by transcranial Doppler (TCD). Methods: The patients who were hospitalized for hypertensive cerebral hemorrhage between August 2014 and February 2017 were selected as the cerebral hemorrhage group and healthy subjects who received physical examination during the same period were selected as the control group;TCD was used to determine the PI of affected-side and unaffected-side middle cerebral artery in cerebral hemorrhage group and lumbar puncture was done to measure intracranial pressure. The serum was collected from the two groups to detect the levels of inflammatory cytokines and nerve injury markers. Results: PI level in affected-side middle cerebral artery of cerebral hemorrhage group was significantly higher than that in the unaffected-side and positively correlated with intracranial pressure level;serum IL-1β, TNF-α, ICAM-1, MMP9, YKL-40, Asp, Glu, NPY, NSE and GFAP levels of cerebral hemorrhage group were significantly higher than those of control group, and serum IL-1β, TNF-α, ICAM-1, MMP9, YKL-40, Asp, Glu, NPY, NSE and GFAP levels of cerebral hemorrhage group of patients with high PI level were significantly higher than those of cerebral hemorrhage group of patients with low PI level. Conclusion: TCD parameters can evaluate the degree of intracranial pressure increase and nerve injury in patients with hypertensive cerebral hemorrhage. 展开更多
关键词 HYPERTENSIVE cerebral hemorrhage TRANSCRANIAL Doppler intracranial pressure Inflammatory response NERVE injury
下载PDF
Therapeutic effect of minimally invasive intracranial hematoma evacuation in the treatment of hypertensive cerebral hemorrhage and TCD evaluation
3
作者 Zi-Hao Zhang Wen-Liang Zhang +7 位作者 Ye Liu Zhi-Bao Wu Liang Liu Pu Gao Ning Gan Shu-Zhang An Hong-Chuan Guo Min Zhou 《Journal of Hainan Medical University》 2017年第6期135-138,共4页
Objective:To explore the therapeutic effect of minimally invasive intracranial hematoma evacuation in the treatment of hypertensive cerebral hemorrhage and the value of dynamic TCD monitoring in predicting the neurolo... Objective:To explore the therapeutic effect of minimally invasive intracranial hematoma evacuation in the treatment of hypertensive cerebral hemorrhage and the value of dynamic TCD monitoring in predicting the neurological function recovery.Methods: A total of 70 patients with hypertensive cerebral hemorrhage who were admitted in our hospital were included in the study and divided into the minimally invasive group and conservative group with 35 cases in each group according to different treatment protocols. The patients in the two groups were given drug conservative treatments. On this basis, the patients in the minimally invasive group were given urokinase in combined with minimally invasive hematoma puncture with YL-1 type needle. TCD was performed before treatment, 1 d, 5 d, 10 d, and 21 d after treatment. The hematoma and edema volume was calculated. NIHSS was used to evaluate the neurological function recovery.Results: Vs, Vd, and Vm after treatment in the minimally invasive group were significantly elevated, while PI was significantly reduced. Vs, Vd, and Vm after treatment in the conservative group were reduced first and elevated later, while PI was elevated first and reduced later, and reached the lowest/peak 10d after treatment. Vs, Vd, and Vm 5 d, 10 d, and 21 d after treatment in the minimally invasive group were significantly higher than those in the conservative group, while PI was significantly lower than that in the conservative group. The hematoma and edema volume after treatment in the two groups was significantly reduced. The hematoma and edema volume at each timing point was significantly lower than that in the conservative group. NIHSS score after treatment in the minimally invasive group was significantly reduced. NIHSS score in the conservative group was elevated first and reduced later, reached the peak 10d after treatment, and at each timing point was higher than that in the minimally invasive group.Conclusions:The early minimally invasive operation can significantly improve the hematoma adjacent blood flow volume in patients with hypertensive cerebral hemorrhage, and contribute to the neurological function recovery. TCD not only can be applied in the dynamic monitoring of cerebral blood flow volume in patients with hypertensive cerebral hemorrhage, but also has a certain value in evaluating the prognosis of neurological function. 展开更多
关键词 HYPERTENSIVE cerebral hemorrhage MINIMALLY invasive intracranial hematoma EVACUATION TCD NIHSS score
下载PDF
Effect of minimally invasive evacuation of hematoma combined with Xingnaojing therapy on neurological function injury and cytokine level in patients with hypertensive cerebral hemorrhagen
4
作者 Yong-Feng Li Wei Li 《Journal of Hainan Medical University》 2017年第6期122-126,共5页
Objective:To study the effect of minimally invasive evacuation of hematoma combined with Xingnaojing therapy on neurological function damage and cytokine level in patients with hypertensive cerebral hemorrhage.Methods... Objective:To study the effect of minimally invasive evacuation of hematoma combined with Xingnaojing therapy on neurological function damage and cytokine level in patients with hypertensive cerebral hemorrhage.Methods:A total of 80 patients with hypertensive cerebral hemorrhage treated in our hospital between June 2010 and September 2015 were selected as the research subjects, the treatment methods and test results were reviewed, and then they were divided into the control group (n=45) who accepted minimally invasive evacuation of hematoma alone and the observation group (n=35) who accepted minimally invasive evacuation of hematoma combined with Xingnaojing therapy. Before and after treatment, cerebral blood flow detector was used to detect cerebral blood flow parameters;ELISA method was used to detect serum levels of neurological function indexes and inflammatory cytokines;high performance liquid chromatograph was used to detect serum neurotransmitter levels. Results: Before treatment, the differences in cerebral blood flow parameters, neurological function indexes, inflammatory cytokines and neurotransmitters were not statistically significant between two groups of patients. After treatment, cerebral blood flow parameters Q and V levels of observation group were higher than those of control group while R level was lower than that of control group;serum NSE, NPY, IL-1β, IL-4, IL-6, TNF-α, Glu and Asp contents of observation group were lower than those of control group while BDNF and Gly contents were higher than those of control group.Conclusion: Minimally invasive evacuation of hematoma combined with Xingnaojing therapy can improve the neurological function and regulate the synthesis of inflammatory cytokines and neurotransmitters in patients with hypertension cerebral hemorrhage. 展开更多
关键词 hypertension cerebral hemorrhage MINIMALLY invasive EVACUATION of hematoma XINGNAOJING NEUROLOGICAL function Inflammatory cytokines
下载PDF
Effect of urokinase in combined with minimally invasive hematoma puncture with YL-1 type needle on the blood sugar and serum CRP in patients with hypertensive cerebral hemorrhage
5
作者 Hui-Hua Lv 《Journal of Hainan Medical University》 2017年第5期120-123,共4页
Objective:To observe the clinical efficacy of urokinase in combined with minimally invasive hematoma puncture with YL-1 type needle in the treatment of hypertensive cerebral hemorrhage and the effect on blood sugar an... Objective:To observe the clinical efficacy of urokinase in combined with minimally invasive hematoma puncture with YL-1 type needle in the treatment of hypertensive cerebral hemorrhage and the effect on blood sugar and serum CRP.Methods:A total of 84 patients with hypertensive cerebral hemorrhage who were admitted in our hospital were included in the study and divided into the minimally invasive group (n=53) and the conservative group (n=31) according to different treatment protocols. The patients in the two groups were given routine drug treatments. The patients in the observation group were given urokinase in combined with minimally invasive hematoma puncture with YL-1 type needle. The blood sugar and serum CRP levels before and after treatment in the two groups were compared. CT was performed to reexamine the cerebral hematoma and edema volume.Results: The serum CRP and blood sugar levels 3, 7 and 14 d after treatment in the minimally invasive group were significantly lower than those in the conservative group (P<0.05). The cerebral hematoma and edema volume 1, 3, 7, and 14 d after treatment in the minimally invasive group was significantly lower than that in the conservative group (P<0.05).Conclusions: Urokinase in combined with minimally invasive hematoma puncture with YL-1 type needle in the treatment of hypertensive cerebral hemorrhage can significantly alleviate the brain tissue injury, reduce the systemic inflammatory reaction and blood sugar level, and contribute to the rehabilitation. 展开更多
关键词 Hypertensive cerebral hemorrhage UROKINASE YL-1 hematoma PUNCTURE NEEDLE MINIMALLY invasive surgery CRP Blood sugar
下载PDF
血清TSP-1联合MMP-9对高血压脑出血患者血肿清除术后发生迟发性脑水肿的预测价值 被引量:1
6
作者 孙龙 董致郅 吴彦青 《检验医学与临床》 CAS 2024年第11期1515-1519,共5页
目的探讨血清血小板反应蛋白(TSP)-1联合基质金属蛋白酶(MMP)-9对高血压脑出血(HCH)患者血肿清除术后发生迟发性脑水肿的预测价值。方法选取2020年1月至2023年6月北京市怀柔区中医医院和首都医科大学附属北京中医医院收治的126例HCH患... 目的探讨血清血小板反应蛋白(TSP)-1联合基质金属蛋白酶(MMP)-9对高血压脑出血(HCH)患者血肿清除术后发生迟发性脑水肿的预测价值。方法选取2020年1月至2023年6月北京市怀柔区中医医院和首都医科大学附属北京中医医院收治的126例HCH患者作为研究对象。所有患者均接受血肿清除手术治疗。观察所有患者术后迟发性脑水肿的发生情况,根据是否发生迟发性脑水肿分为发生组和未发生组。比较两组临床资料,采用多因素Logistic回归分析HCH患者血肿清除术后发生迟发性脑水肿的危险因素。绘制受试者工作特征(ROC)曲线评估血清TSP-1、MMP-9对HCH患者血肿清除术后发生迟发性脑水肿的预测价值。结果126例HCH患者血肿清除术后有35例患者发生迟发性脑水肿,有91例患者未发生迟发性脑水肿。发生组血清TSP-1、MMP-9水平高于未发生组,血肿体积大于未发生组,差异均有统计学意义(P<0.05)。ROC曲线分析结果显示,血清TSP-1、MMP-9单独及2项指标联合预测HCH患者血肿清除术后发生迟发性脑水肿的曲线下面积分别为0.761、0.769、0.810。多因素Logistic回归分析结果显示,TSP-1≥75.440 ng/mL、MMP-9≥183.265μg/L、血肿体积≥50.50 mL是HCH患者血肿清除术后发生迟发性脑水肿的危险因素(P<0.05)。结论血清TSP-1、MMP-9联合预测HCH患者血肿清除术后发生迟发性脑水肿的效能较高,二者有望成为预测其发生的有效指标,可为后续临床诊疗提供指导。 展开更多
关键词 高血压脑出血 血肿清除术 迟发性脑水肿 血小板反应蛋白-1 基质金属蛋白酶-9
下载PDF
注射体积对老年患者中等量基底节区脑出血微创穿刺术后临床疗效的影响
7
作者 王亮 董伟 +3 位作者 郑炼 张金淼 袁丁 陈果 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2024年第5期268-273,共6页
目的探讨药物总量控制下注射体积对老年患者中等量基底节区脑出血微创穿刺术后临床疗效的影响。方法以血肿最大层面长轴中心点为穿刺点,CT引导穿刺,穿刺成功后抽吸液态血肿,控制血肿腔内单次尿激酶总量4.0×10^(4)U,注射体积分别为2... 目的探讨药物总量控制下注射体积对老年患者中等量基底节区脑出血微创穿刺术后临床疗效的影响。方法以血肿最大层面长轴中心点为穿刺点,CT引导穿刺,穿刺成功后抽吸液态血肿,控制血肿腔内单次尿激酶总量4.0×10^(4)U,注射体积分别为2 mL和4 mL,根据术后CT结果调整针体深度,并根据血肿清除情况拔针。比较两组术后血肿清除率、颅内压、血肿周围水肿体积、总死亡率、并发症发生率、神经功能缺失评分(neurological deficit score,NDS)和日常生活能力评定(activities of daily living,ADL)结果。结果两组患者术后首次血肿清除率(31.17%±1.46%vs.30.50%±1.69%)、术后颅内压、总死亡率无明显差异(P均>0.05)。大体积组术后1 d(77.30%±3.75%vs.62.77%±3.89%),2 d(91.43%±4.05%vs.80.12%±4.15%),拔针前(92.35%±4.83%vs.85.9%±3.59%)血肿清除率明显高于小体积组(P<0.05)。大体积组留针时间(1.8 d±0.2 d vs.3.1 d±0.4 d,P<0.05)、尿激酶总用量(24.3×10^(4)U±2.3×10^(4)U vs.36.5×10^(4)U±4.7×10^(4)U,P<0.05)均少于小体积组(P<0.05)。大体积组术后3 d(11.33 mL±2.32 mL vs.16.45 mL±1.97 mL)、5 d(14.59 mL±2.11 mL vs.21.37 mL±2.43 mL)、7 d(22.79 mL±3.15 mL vs.30.15 mL±4.04 mL)、14 d(12.41 mL±1.95 mL vs.19.38 mL±2.47 mL)血肿周围水肿体积少于小体积组(P<0.05)。大体积组术后28 d、3个月、6个月NDS[分别为(22.35±2.49 vs.28.14±2.95)、(16.43±2.17 vs.23.81±2.56)、(11.39±1.87 vs.17.74±2.03)]及ADL评分[分别为(44.76±4.22 vs.36.15±2.36)、(62.55±3.81 vs.51.39±2.45)、(77.53±3.76 vs.60.81±4.35)]优于小体积组(P<0.05)。大体积组术后并发症发生率低于小体积组(P<0.05)。结论大体积注射法能更有效引流血肿,缩短留针时间,减少尿激酶用量,降低术后并发症发生率,改善患者预后,是老年中等量基底节区脑出血微创穿刺术后提高疗效的有效方法。 展开更多
关键词 微创穿刺 基底节区 脑出血 体积 老年 血肿清除率 颅内压
下载PDF
神经内镜血肿清除术联合颅内压监测在高血压脑出血患者中的应用效果分析
8
作者 刘欢 刘红彬 +1 位作者 叶勇强 薛芳 《中国医刊》 CAS 2024年第11期1205-1208,共4页
目的探讨神经内镜血肿清除术联合颅内压监测在高血压脑出血(HICH)患者中的应用效果。方法选取2018年1月至2022年1月四川省资阳市中心医院收治的64例HICH患者为研究对象,根据手术方式不同将研究对象分为对照组(给予神经内镜血肿清除术)... 目的探讨神经内镜血肿清除术联合颅内压监测在高血压脑出血(HICH)患者中的应用效果。方法选取2018年1月至2022年1月四川省资阳市中心医院收治的64例HICH患者为研究对象,根据手术方式不同将研究对象分为对照组(给予神经内镜血肿清除术)和观察组(给予神经内镜血肿清除术联合颅内压监测),每组32例。比较分析两组患者的临床特征、围手术期相关指标。比较分析两组患者术后6个月的预后及并发症发生情况。结果两组患者的脑出血侧别、脑血肿体积、脑出血位置、中线偏移比较差异均无统计学意义(P>0.05)。观察组患者的血肿清除率高于对照组,甘露醇用量、出院时的Rankin量表评分、术后住院时间均低于或短于对照组,差异均有统计学意义(P<0.05)。两组患者术后6个月的并发症总发生率比较差异无统计学意义(P>0.05);观察组患者术后6个月的Rankin量表评分低于对照组,差异有统计学意义(P<0.05)。结论神经内镜血肿清除术联合颅内压监测可显著改善HICH患者的预后,且安全性较好。 展开更多
关键词 神经内镜血肿清除术 颅内压监测 高血压脑出血 预后
下载PDF
经立体定向引导前额锁孔入路神经内镜下血肿清除术治疗高血压基底节区脑出血的短期效果
9
作者 关毅 任振强 龙江 《精准医学杂志》 2024年第6期527-530,534,共5页
目的分析经立体定向引导前额锁孔入路神经内镜下血肿清除术治疗高血压基底节区脑出血(hypertensive basal ganglia hemorrhage,HBGH)的短期效果。方法选取2016年12月—2021年8月我院神经外科HBGH患者148例,依据不同手术方案分为研究组... 目的分析经立体定向引导前额锁孔入路神经内镜下血肿清除术治疗高血压基底节区脑出血(hypertensive basal ganglia hemorrhage,HBGH)的短期效果。方法选取2016年12月—2021年8月我院神经外科HBGH患者148例,依据不同手术方案分为研究组和对照组。行常规立体定向血肿穿刺引流术的74例为对照组,行立体定向引导下前额锁孔入路神经内镜血肿清除术的74例为研究组。比较两组患者手术用时、住院期间再出血发生比例、术后6 h血肿清除比例、术前和术后3个月欧洲脑卒中量表(ESS)评分及日常生活能力(Barthel)指数、术后3个月死亡发生比例、术后3个月并发症发生比例、术后6个月预后良好比例。结果研究组手术用时长于对照组(t=19.084,P<0.05),住院期间再出血发生比例低于对照组(χ^(2)=9.378,P<0.05)。研究组患者术后6 h血肿清除比例高于对照组(u=2.935,P<0.05);术后3个月,研究组患者ESS评分、Barthel指数手术前后差值显著高于对照组(t=8.349、9.474,P<0.05),而死亡发生比例、并发症发生比例两组比较无明显差异(P>0.05);术后6个月,研究组预后良好比例高于对照组(χ^(2)=9.483,P<0.05)。结论经立体定向引导前额锁孔入路神经内镜下血肿清除术治疗HBGH手术时间虽较长,但能提高血肿清除率、降低术后再出血率,预后效果良好,并可改善患者神经功能及生活能力,且安全性高。 展开更多
关键词 颅内出血 高血压性 立体定位技术 神经内窥镜检查 血肿 治疗结果 预后
下载PDF
电磁导航辅助神经内镜血肿清除术治疗高血压脑出血患者的临床效果
10
作者 杜娟 刘婷婷 陈素杰 《医学临床研究》 CAS 2024年第7期1051-1053,1057,共4页
【目的】探讨电磁导航辅助神经内镜血肿清除术治疗高血压脑出血(HICH)患者的效果及对患者短期预后的影响。【方法】回顾性分析2020年3月至2023年3月本院收治的102例HICH患者的临床资料,根据手术方案不同将其分为观察组(行电磁导航辅助... 【目的】探讨电磁导航辅助神经内镜血肿清除术治疗高血压脑出血(HICH)患者的效果及对患者短期预后的影响。【方法】回顾性分析2020年3月至2023年3月本院收治的102例HICH患者的临床资料,根据手术方案不同将其分为观察组(行电磁导航辅助神经内镜血肿清除术治疗)和对照组(行常规神经内镜血肿清除术治疗),每组51例。比较两组围术期指标、手术前后美国国立卫生研究院卒中量表(NIHSS)评分、改良Rankin量表(mRS)评分、氧化应激指标[氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)、丙二醛(MDA)]、血管内皮功能指标[血管升压素(AVP)、血管生成素-1(Ang-1)、内皮素(ET)]及并发症发生情况。【结果】观察组术后血肿残余量低于对照组,血肿清除率高于对照组,住院时间短于对照组,差异有统计学意义(P<0.05)。术后1个月、3个月,两组NIHSS、mRS评分低于术前,且观察组低于对照组,差异有统计学意义(P<0.05)。术后1个月,两组血清SOD、GSH-Px水平高于术前,血清MDA水平低于术前,且两组上述指标比较,差异均有统计学意义(P<0.05)。术后1个月,两组血清AVP、Ang-1、ET水平低于术前,且观察组低于对照组,差异有统计学意义(P<0.05)。观察组并发症发生率低于对照组,差异有统计学意义(P<0.05)。【结论】电磁导航辅助神经内镜血肿清除术有助于改善HICH患者神经功能及预后,优化围术期指标,缓解氧化应激状态,改善患者血管内皮功能,降低并发症发生风险。 展开更多
关键词 颅内出血 高血压性/外科学 神经内窥镜检查 血肿/外科学 预后
下载PDF
神经内镜下脑血肿清除术与小骨窗开颅清除术治疗高血压脑出血的有效性及安全性分析
11
作者 张学基 卫明 +3 位作者 孙静波 李殿炜 郭树铭 李青霞 《中外医疗》 2024年第32期46-49,共4页
目的探讨高血压脑出血患者分别采用小骨窗开颅清除术(以下简称为“小骨术”)和神经内镜下脑血肿清除术(以下简称“内镜术”)治疗的临床效果和安全性。方法随机选取2019年5月—2023年5月甘肃省中医院收治的80例高血压脑出血患者作为研究... 目的探讨高血压脑出血患者分别采用小骨窗开颅清除术(以下简称为“小骨术”)和神经内镜下脑血肿清除术(以下简称“内镜术”)治疗的临床效果和安全性。方法随机选取2019年5月—2023年5月甘肃省中医院收治的80例高血压脑出血患者作为研究对象,依据不同的手术方式将观察对象分为两组,各40例。对照组采用小骨术治疗,观察组采用内镜术治疗,对比两组的治疗效果、神经功能缺损程度、神经功能恢复状态、意识状态和并发症发生情况。结果观察组术中出血量少于对照组,手术时间和住院时间均短于对照组,差异有统计学意义(P均<0.05)。出院时,观察组美国国立卫生研究院卒中量表评分、改良Rankin量表评分均低于对照组,格拉斯哥昏迷评分高于对照组,差异有统计学意义(P均<0.05)。观察组的并发症发生率为2.50%(1/40),低于对照组的20.00%(8/40),差异有统计学意义(χ2=4.507,P<0.05)。结论对于确诊为高血压脑出血且需要采取手术治疗的患者,内镜术的治疗效果明显优于小骨术,且前者能减少术中出血量,缩短手术时间和住院时间,改善神经功能和意识状态,减少并发症的发生。 展开更多
关键词 高血压脑出血 神经内镜下脑血肿清除术 小骨窗开颅清除术 安全性
下载PDF
不同入路小骨窗开颅显微手术治疗基底节区高血压脑出血的效果比较
12
作者 袁鹏 张清华 杨艳华 《当代医学》 2024年第16期50-54,共5页
目的分析不同入路小骨窗开颅显微手术治疗基底节区高血压脑出血的效果。方法选取2019年1月至2022年3月丰城市人民医院收治的88例基底节区高血压脑出血患者作为研究对象,随机分为观察组与对照组,每组44例。两组均行小骨窗开颅显微手术,... 目的分析不同入路小骨窗开颅显微手术治疗基底节区高血压脑出血的效果。方法选取2019年1月至2022年3月丰城市人民医院收治的88例基底节区高血压脑出血患者作为研究对象,随机分为观察组与对照组,每组44例。两组均行小骨窗开颅显微手术,对照组采用经颞叶皮质入路手术治疗,观察组采用经侧裂下Rolandic点-岛叶入路手术治疗,比较两组手术情况、血肿清除率、再出血率、术后并发症、术后1个月格拉斯哥昏迷量表(Glasgow coma score,GOS)分级情况及术后1、3、6个月的美国国立卫生研究院卒中量表(National Institute of Health stroke scale,NIHSS)评分及世界卫生组织生存质量测定量表(World Health Organization on quality of life brief scale,WHOQOL-BREF)评分。结果两组手术时间、术中出血量、引流管放置时间、行大骨瓣减压例数、住院时间比较差异均无统计学意义;观察组开始手术至颅内压下降时间长于对照组,差异有统计学意义(P<0.05)。观察组术后24 h血肿清除率明显高于对照组,差异有统计学意义(P<0.05);两组再出血率比较差异无统计学意义。观察组术后1个月预后良好率为81.82%,高于对照组的61.36%,差异有统计学意义(P<0.05)。术后1、3、6个月,观察组NIHSS评分均低于对照组,WHOQOL-BREF评分均高于对照组,差异有统计学意义(P<0.05)。观察组术后并发症发生率为6.82%,低于对照组的25.00%,差异有统计学意义(P<0.05)。结论经侧裂下Rolandic点-岛叶入路小骨窗开颅显微手术治疗基底节区高血压脑出血的效果显著,有助于提升血肿清除率,减少术后并发症发生率,促进术后神经功能的恢复,提高患者预后生存质量。 展开更多
关键词 小骨窗开颅显微手术 基底节区 高血压脑出血 经侧裂下Rolandic点-岛叶入路 血肿清除率 并发症
下载PDF
神经内镜微创手术治疗高血压脑出血的效果分析 被引量:1
13
作者 徐畅 玉山江·阿合尼牙孜 +1 位作者 秦智勇 王和功 《中国社区医师》 2024年第1期33-35,共3页
目的:分析神经内镜微创手术治疗高血压脑出血的效果。方法:选取2020年1月—2022年12月新疆生产建设兵团第一师医院收治的高血压脑出血患者120例作为研究对象,依据双色球法分为观察组与对照组,各60例。对照组采取开颅血肿清除术治疗,观... 目的:分析神经内镜微创手术治疗高血压脑出血的效果。方法:选取2020年1月—2022年12月新疆生产建设兵团第一师医院收治的高血压脑出血患者120例作为研究对象,依据双色球法分为观察组与对照组,各60例。对照组采取开颅血肿清除术治疗,观察组采取神经内镜微创手术治疗。比较两组临床疗效。结果:观察组手术时间短于对照组,术中出血量少于对照组,血肿清除率高于对照组,差异有统计学意义(P<0.001)。观察组术后并发症发生率低于对照组,差异有统计学意义(P=0.031)。观察组治疗总有效率高于对照组,差异有统计学意义(P=0.028)。观察组重症监护室观察时间及整体治疗时间短于对照组,差异有统计学意义(P<0.001)。结论:神经内镜微创手术治疗高血压脑出血的效果较好,其手术时间短、术中出血量少、血肿清除率高,术后并发症发生率低,患者恢复速度快。 展开更多
关键词 开颅血肿清除术 神经内镜微创手术 高血压脑 出血
下载PDF
清震汤加减联合微创血肿清除术治疗高血压脑出血临床研究
14
作者 王莉 周翠玲 +1 位作者 麻伟兴 李燕 《新中医》 CAS 2024年第10期30-34,共5页
目的:观察清震汤加减联合微创血肿清除术治疗高血压脑出血的治疗效果。方法:抽取98例高血压脑出血患者为研究对象,按照随机数字表法分为试验组和对照组各49例。对照组行微创血肿清除术,术后给予西医常规治疗,试验组在对照组基础上联合... 目的:观察清震汤加减联合微创血肿清除术治疗高血压脑出血的治疗效果。方法:抽取98例高血压脑出血患者为研究对象,按照随机数字表法分为试验组和对照组各49例。对照组行微创血肿清除术,术后给予西医常规治疗,试验组在对照组基础上联合清震汤加减治疗。比较2组颅内压(ICP)、美国国立卫生院卒中量表(NIHSS)评分与格拉斯哥昏迷指数(GCS),脑水肿体积和持续时间,血清肿瘤坏死因子-α(TNF-α)、神经生长因子(NGF)、基质金属蛋白酶-9(MMP-9)水平及中医证候评分。结果:术前,2组ICP值比较,差异无统计学意义(P>0.05);术后即刻及24 h、72 h、1周,试验组相同时间点的ICP值均低于对照组(P<0.05)。术前,2组NIHSS、GCS指数评分比较,差异无统计学意义(P>0.05);术后14 d,试验组NIHSS评分低于对照组(P<0.05),GCS指数高于对照组(P<0.05)。术后,试验组脑水肿体积、脑水肿持续时间低于对照组,差异有统计学意义(P<0.05)。术前,2组血清TNF-α、MMP-9、NGF水平比较,差异无统计学意义(P>0.05)。术后14 d,2组血清TNF-α、MMP-9水平较术前下降(P<0.05),血清NGF水平较术前上升(P<0.05);且试验组血清TNF-α、MMP-9水平低于对照组(P<0.05),NGF水平高于对照组(P<0.05)。术前,2组半身不遂、口眼歪斜、神志昏蒙等中医证候评分比较,差异无统计学意义(P>0.05);术后14 d,试验组上述各项中医证候评分均低于对照组(P<0.05)。结论:微创血肿清除术联合清震汤加减治疗高血压脑出血可降低ICP,减轻卒中症状和昏迷指数,减轻脑水肿,改善中医证候及炎症反应。 展开更多
关键词 高血压脑出血 微创血肿清除术 清震汤 颅内压 脑水肿 炎症因子
下载PDF
机器人导航辅助脑深部血肿穿刺引流术治疗高血压性脑出血的临床效果分析
15
作者 李曦男 颜扬 孔凡根 《医学临床研究》 CAS 2024年第9期1361-1364,共4页
【目的】探讨机器人导航辅助脑深部血肿穿刺引流术治疗高血压性脑出血的临床效果。【方法】回顾性分析2022年1月至2023年12月本院收治的42例高血压性脑出血患者的临床资料,根据手术方式不同分为开颅显微镜手术组(显微镜组,n=15)、小骨... 【目的】探讨机器人导航辅助脑深部血肿穿刺引流术治疗高血压性脑出血的临床效果。【方法】回顾性分析2022年1月至2023年12月本院收治的42例高血压性脑出血患者的临床资料,根据手术方式不同分为开颅显微镜手术组(显微镜组,n=15)、小骨窗内镜手术组(内镜组,n=11)、机器人导航穿刺引流组(机器人穿刺组,n=16)。比较三组患者一般资料及术前格拉斯哥昏迷评分(GCS评分)、术后格拉斯哥预后评分(GOS评分)、手术前后肌力情况、预后情况。【结果】三组性别、年龄、血肿量、中线偏移、GCS评分、术前肌力、GOS评分、术前肌力、术后肌力、去骨瓣减压所占比例、入住ICU时间、入住普通病房时间、死亡情况比较,差异均无统计学意义(P>0.05)。三组患者术前均存在不同程度的肌力受损情况,经不同的手术方式治疗后,肌力均得到明显好转。【结论】机器人导航辅助脑深部血肿穿刺引流术治疗出血量在20~50 mL的高血压性脑出血患者,临床效果较好,安全性较高,对促进患者神经功能恢复、缩短治疗周期、改善患者预后具有积极作用。 展开更多
关键词 颅内出血 高血压性/外科学 血肿/外科学 机器人手术 穿刺术/方法 引流术/方法
下载PDF
内镜辅助鞘在高血压脑出血脑内血肿清除术中的应用
16
作者 杜战锋 王茂德 +2 位作者 姜海涛 王拓 李琦 《哈尔滨医药》 2024年第3期32-35,共4页
目的分析内镜辅助鞘在高血压脑出血(HICH)脑内血肿清除术中的应用。方法选择89例高血压脑出血患者进行研究,根据脑内血肿清除术中是否采用新型可调式神经内镜辅助鞘进行分组,分为有鞘组(n=47)、无鞘组(n=42),比较两组手术情况、临床指... 目的分析内镜辅助鞘在高血压脑出血(HICH)脑内血肿清除术中的应用。方法选择89例高血压脑出血患者进行研究,根据脑内血肿清除术中是否采用新型可调式神经内镜辅助鞘进行分组,分为有鞘组(n=47)、无鞘组(n=42),比较两组手术情况、临床指标情况、并发症情况及预后发展。结果有鞘组手术时间、术中出血量小于无鞘组,其血肿清除率明显高于无鞘组(P<0.05);与术前比较,两组术后器官功能衰竭评分(SOFA)、急性生理学及慢性健康状况评分系统Ⅱ(APACHE-Ⅱ)、美国国立卫生研究院卒中量表(NIHSS)评分明显降低,且有鞘组各项评分均低于无鞘组(P<0.05);有鞘组颅内感染、癫痫、肺部感染、应激性溃疡发生率明显低于无鞘组(P<0.05);有鞘组预后Ⅱ-V级患者分别有3、9、21、14例,无鞘组预后Ⅱ-V级患者分别有11、15、11、5例,两组预后比较差异具有统计学意义(P<0.05)。结论新型可调式神经内镜辅助鞘在HICH脑内血肿清除术治疗中的临床实用价值较高,可扩大临床应用范围,提高临床手术治疗效率。 展开更多
关键词 新型可调式神经内镜辅助鞘 脑内血肿清除术 高血压脑出血 临床应用
下载PDF
新型简易徒手锥颅血肿引流术治疗高血压脑出血疗效分析
17
作者 韩若东 张亚飞 +2 位作者 颜秀侠 李博文 钱贝丽 《中国现代神经疾病杂志》 CAS 北大核心 2024年第6期461-470,共10页
目的探讨新型简易徒手锥颅血肿引流术治疗高血压脑出血的疗效。方法共纳入2021年1月至2022年12月安徽医科大学附属亳州医院收治的103例高血压脑出血患者,分别行传统锥颅血肿引流术(传统锥颅组,51例)和新型锥颅血肿引流术(新型锥颅组,52... 目的探讨新型简易徒手锥颅血肿引流术治疗高血压脑出血的疗效。方法共纳入2021年1月至2022年12月安徽医科大学附属亳州医院收治的103例高血压脑出血患者,分别行传统锥颅血肿引流术(传统锥颅组,51例)和新型锥颅血肿引流术(新型锥颅组,52例)。根据手术前后头部CT图像计算血肿清除率,评价引流管置入精准度;采用美国国立卫生研究院卒中量表(NIHSS)评价神经功能缺损程度,改良Rankin量表(mRS)评价神经功能预后。结果新型锥颅组血肿清除率[(45.54±24.23)%对(35.08±6.49)%;t=3.008,P=0.004]和引流管置入精准度[90.38%(47/52)对68.63%(35/51);χ2=7.509,P=0.006]均高于传统锥颅组。新型锥颅组与传统锥颅组血肿量(F=9.157,P=0.003)和mRS评分(F=4.412,P=0.038)差异具有统计学意义,术后新型锥颅组血肿量(t=⁃4.625,P=0.000)和mRS评分(t=⁃2.712,P=0.008)均低于传统锥颅组;两组手术前后血肿量(F=280.635,P=0.000)、NIHSS评分(F=443.320,P=0.000)和mRS评分(F=552.781,P=0.000)差异亦具有统计学意义,新型锥颅组和传统锥颅组术后血肿量(t=10.233,P=0.000;t=19.906,P=0.000)、NIHSS评分(t=14.576,P=0.000;t=15.286,P=0.000)和mRS评分(t=20.201,P=0.000;t=13.511,P=0.000)均低于术前。结论新型简易徒手锥颅血肿引流术治疗高血压脑出血安全、有效。 展开更多
关键词 颅内出血 高血压性 血肿 引流术 体层摄影术 螺旋计算机 神经外科手术
下载PDF
脑出血血肿清除术后颅内感染的病原菌及危险因素
18
作者 柴华 金霞云 +1 位作者 袁海军 何国斌 《中国微侵袭神经外科杂志》 CAS 2024年第8期462-467,共6页
目的分析脑出血血肿清除术后颅内感染的病原菌特点及危险因素,为临床医生预防术后颅内感染、降低感染率提供参考。方法回顾性分析422例脑出血血肿清除术患者临床资料,根据是否发生颅内感染分为感染组和对照组。应用倾向性评分匹配法将... 目的分析脑出血血肿清除术后颅内感染的病原菌特点及危险因素,为临床医生预防术后颅内感染、降低感染率提供参考。方法回顾性分析422例脑出血血肿清除术患者临床资料,根据是否发生颅内感染分为感染组和对照组。应用倾向性评分匹配法将两组患者按1∶1配比。分析感染组的病原菌分布特点,利用多因素Logistic回归分析,观察血肿清除术后发生颅内感染的危险因素并建立相关回归方程。结果经PSM匹配,有132对(共264例)患者匹配成功、纳入研究。感染组132例患者中,共分离得到病原菌32株,其中革兰阳性菌15株,革兰阴性菌16株,真菌1株。多因素分析结果显示:ASA评分>3分、住院时间长、引流管留置时间长、术前白蛋白水平低、术后第3天测得最高体温高是脑出血血肿清除术后颅内感染的独立危险因素;将上述危险因素进行线性拟合获得联合诊断模型:logit(P)=-57.166+1.05×ASA评分>3分+0.104×住院时长+0.169×引流管留置时长-0.114×术前白蛋白水平+1.512×术后第3天测得最高体温,受试者工作特征曲线下面积为0.848,诊断敏感度为87.10%、特异度为65.20%。结论ASA评分>3分、住院时间长、引流管留置时间长、术前白蛋白水平低、术后第3天测得最高体温高是脑出血血肿清除术后颅内感染的独立危险因素,由上述指标建立的联合诊断模型对颅内感染具有较高的诊断价值。 展开更多
关键词 脑出血 血肿清除术 颅内感染 病原菌 危险因素
下载PDF
The effect of hematoma puncture drainage before decompressive craniectomy on the prognosis of hypertensive intracerebral hemorrhage with cerebral hernia at a high altitude 被引量:16
19
作者 Lin-Jie Wei Chi Lin +9 位作者 Xing-Sen Xue Guo-Dong Dun Jian-Bo Zhang Yan-Xiang Tong Jia-Xiong Wang Shi-Ji Yang Ling Wang Zhi Chen Hua Feng Gang Zhu 《Chinese Journal of Traumatology》 CAS CSCD 2021年第6期328-332,共5页
Purpose:Rapid decompressive craniectomy(DC)was the most effective method for the treatment of hypertensive intracerebral hemorrhage(HICH)with cerebral hernia,but the mortality and disability rate is still high.We susp... Purpose:Rapid decompressive craniectomy(DC)was the most effective method for the treatment of hypertensive intracerebral hemorrhage(HICH)with cerebral hernia,but the mortality and disability rate is still high.We suspected that hematoma puncture drainage(PD)+DC may improve the therapeutic effect and thus compared the combined surgery with DC alone.Methods:From December 2013 to July 2019,patients with HICH from Linzhi,Tibet and Honghe,Yunnan Province were retrospectively analyzed.The selection criteria were as follows:(1)altitude≥1500 m;(2)HICH patients with cerebral hernia;(3)Glascow coma scale score of 4-8 and time from onset to admission≤3 h;(4)good liver and kidney function;and(5)complete case data.The included patients were divided into DC group and PD+DC group.The patients were followed up for 6 months.The outcome was assessed by Glasgow outcome scale(GOS)score,Kaplan-Meier survival curve and correlation between time from admission to operation and prognosis.A good outcome was defined as independent(GOS score,4-5)and poor outcome defined as dependent(GOS score,3-1).All data analyses were performed using SPSS 19,and comparison between two groups was conducted using separatet-tests or Chi-square tests.Results:A total of 65 patients was included.The age ranged 34-90 years(mean,63.00±14.04 years).Among them,31 patients had the operation of PD+DC,whereas 34 patients underwent DC.The two groups had no significant difference in the basic characteristics.After 6 months of follow-up,in the PD+DC group there were 8 death,4 vegetative state,4 severe disability(GOS score 1-3,poor outcome 51.6%);8 moderate disability,and 7 good recovery(GOS score 4-5,good outcome 48.4%);while in the DC group the result was 15 death,6 vegetative state,5 severe disability(poor outcome 76.5%),4 moderate disability and 4 good recovery(good outcome 23.5%).The GOS score and good outcome were significantly less in DC group than in PD+DC group(Z=-1.993,p=0.046;χ2=4.38,p=0.043).However,there was no significant difference regarding the survival curve between PD+DC group and DC group.The correlation between the time from admission to operation and GOS at 6 months(r=-0.41,R2=0.002,p=0.829)was not significant in the PD+DC group,but significant in the DC group(r=-0.357,R2=0.128,p=0.038).Conclusion:PD+DC treatment can improve the good outcomes better than DC treatment for HICH with cerebral hernia at a high altitude. 展开更多
关键词 intracranial hemorrhage HYPERTENSIVE High altitude cerebral hernia hematoma puncture drainage Decompressive craniectomy
原文传递
神经内镜下经额叶入路血肿清除术对高血压性脑出血患者脑血流灌注及短期预后的影响 被引量:1
20
作者 徐四军 《河南医学研究》 CAS 2024年第5期864-868,共5页
目的观察神经内镜下经额叶入路血肿清除术对高血压性脑出血患者脑血流灌注以及短期预后的影响。方法采用前瞻性随机对照研究,选择2020年6月至2022年6月驻马店市中医院需行神经内镜下血肿清除术治疗的79例高血压性脑出血患者作为研究对象... 目的观察神经内镜下经额叶入路血肿清除术对高血压性脑出血患者脑血流灌注以及短期预后的影响。方法采用前瞻性随机对照研究,选择2020年6月至2022年6月驻马店市中医院需行神经内镜下血肿清除术治疗的79例高血压性脑出血患者作为研究对象,采用随机数字表法将患者分为A组与B组,其中A组接受神经内镜下经额叶入路血肿清除术治疗,B组接受神经内镜下经颞叶皮质血肿清除术治疗。比较两组患者术后2个月短期疗效、围手术期指标(手术时间、术中出血量、血肿清除率、住院时间)、脑血流灌注指标[局部脑血流量(rCBF)、对比剂平均通过时间(MTT)、局部脑血容量(rCBV)]以及术后并发症。结果A组患者术后2个月临床疗效优于B组,A组患者血肿清除率高于B组,差异有统计学意义(P<0.05)。两组患者住院时间、术中出血量、手术时间方面比较,差异无统计学意义(P>0.05)。术前两组患者rCBV、rCBF以及MTT比较,差异无统计学意义(P>0.05);术后两组患者rCBV、rCBF均上升,MTT均下降,且A组与B组相比,差异有统计学意义(P<0.05)。两组患者均出现术后并发症,但组间比较差异无统计学意义(P>0.05)。结论神经内镜下经额叶入路血肿清除术可有效提高高血压性脑出血患者短期疗效及血肿清除率,改善颅脑血供情况。 展开更多
关键词 神经内镜 血肿清除术 高血压性脑出血 脑血流灌注 短期预后
下载PDF
上一页 1 2 61 下一页 到第
使用帮助 返回顶部